Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-44.88	-5.76	-3.97
Graham Fair Price	44.76	0.41	0.28
PEG	36.98	-0.05	-0.09
Price/Book	8.03	0.08	0.07
Price/Cash Flow	-99.71	4.72	-1601.40
Prices/Earnings	45.99	-5.49	-10.17
Price/Sales	-52.18	1.21	2.54
Price/FCF	-99.71	4.72	-1601.40
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-46.48	0.54	1.00
Operating Margin	50.46	-0.20	-0.40
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-100.00
ROIC	0.02	0.02	8.76
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	3.42	-0.80	327.95
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.28	-0.12	57.64
EPS QOQ	-1.17	-1.00	14.29
FCF QOQ	-1.00	367.72	36568.15
Revenue QOQ	-0.56	1.26	125.37
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	454.26	100.00
Days Sales Outstanding (DSO)	0.00	709.04	100.00
Inventory Turnover	0.00	0.20	100.00
Debt/Capitalization	0.02	0.08	284.50
Quick Ratio	2.04	0.52	-74.46
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.39	1.42	2.36
Cash	0.20	0.21	5.08
Capex	< 0.005	< 0.005	222.26
Free Cash Flow	< 0.005	0.02	37437.90
Revenue	0.04	0.09	131.23
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.04	1.42	-30.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-10.07	11.66	15.85
Naive Interpretation	Member

06 - Financial Health · Weak

Rating